Roelof Rongen

Roelof Rongen is the founder of Matinas BioPharma, Inc., founded in 2011, serving as President, Chief Executive Officer & Director.
Mr. Rongen was the founder of Innovative Molecules GmbH, founded in 2019, serving as Chief Executive Officer.
Mr. Rongen is also the founder of Essential Fatty Acid Therapeutics LLC..
Mr. Rongen is Chief Executive Officer & Director at Adolore Biotherapeutics, Inc. since 2022.
Mr. Rongen is Independent Director at GRI Bio, Inc. since 2023.
Former positions include Chief Executive Officer & Director at Matinas BioPharma Holdings, Inc. from 2016 to 2018, Executive Director-Marketing at Logistics & Environmental Solutions Corp., Director at Vallon Pharmaceuticals, Inc., Vice President-Life Cycle Management at Reliant Pharmaceuticals LLC from 2000 to 2008, and Executive VP-North American Operations at Trygg Pharma AS from 2009 to 2012.
Education includes undergraduate studies at Wageningen University and an MBA from Kellogg School of Management.